Farther Finance Advisors’s Harmony Biosciences HRMY Stock Holding History

Farther Finance Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1K	Sell	306 -28	-8%	-$883	﹤0.01%	4352
2026 Q1	$9.34K	Sell	334 -302	-47%	-$9.9K	﹤0.01%	4157
2025 Q4	$23.8K	Buy	636 +618	+3,433%	+$20.3K	﹤0.01%	3325
2025 Q3	$496	Sell	18 -111	-86%	-$3.82K	﹤0.01%	4545
2025 Q2	$4.08K	Sell	129 -95	-42%	-$3.06K	﹤0.01%	3440
2025 Q1	$7.26K	Buy	224 +218	+3,633%	+$7.82K	﹤0.01%	2890
2024 Q4	$206	Hold	6	–	–	﹤0.01%	3654
2024 Q3	$239	Buy	6 +1	+20%	+$35	﹤0.01%	3609
2024 Q2	$152	Buy	5 +2	+67%	+$60	﹤0.01%	3537
2024 Q1	$99	Hold	3	–	–	﹤0.01%	3381
2023 Q4	$97	Sell	3 -7	-70%	-$195	﹤0.01%	3305
2023 Q3	$328	Buy	+10	New	+$347	﹤0.01%	2363
2023 Q2	–	Sell	-3	Closed	-$98	–	2530
2023 Q1	$98	Hold	3	–	–	﹤0.01%	2285
2022 Q4	$165	Buy	+3	New	+$165	﹤0.01%	2069

Other funds holding HRMY

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Farther Finance Advisors's HRMY Position: Q2 2026 in Review

Farther Finance Advisors reduced its Harmony Biosciences (HRMY) stake by 8.4% in Q2 2026, selling an estimated $883 and leaving 306 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4352.

Farther Finance Advisors first reported a position in HRMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $23.8K in Q4 2025. 40 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Farther Finance Advisors held 306 shares of Harmony Biosciences worth $11.1K as of Q2 2026.
Farther Finance Advisors sold 28 Harmony Biosciences shares in Q2 2026, an estimated $883.
Harmony Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4352 holding.
Farther Finance Advisors first reported a position in Harmony Biosciences in Q4 2022 and has held it in 14 quarters since.
Farther Finance Advisors's Harmony Biosciences position peaked at $23.8K in Q4 2025.
40 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.